Current role
Dr. William K. Schmidt
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. William K. Schmidt
Ensysce Biosciences, Inc. reported in an 8-K filed September 16, 2022 that Dr. William K. Schmidt was appointed interim Chief Medical Officer, effective September 15, 2022.
“The Company has appointed Dr. William K. Schmidt, Ph.D. as the Company's interim Chief Medical Officer, effective as of September 15, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Ensysce Biosciences, Inc. (ENSC)
SEC 8-K
Current2022-09-15–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ensysce Biosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Lynn Kirkpatrick CEO, Board Member
- Bob Gower Chairman, Board Member
- David Humphrey CFO
- Adam Levin Board Member
- Adam S. Levin Board Member
- Andrew Benton Board Member
- Dr. Lynn Kirkpatrick Board Member
- James Morrison Board Member
- Steve R. Martin Board Member
- William Chang Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.